OverviewSuggest Edit

Polyplus-transfection is a biotechnology company. It develops and sells solutions for the delivery of nucleic acids in research, bioproduction, and therapeutics. The company also supplies a wide range of reagents for the transfection of genes, oligonucleotides, and siRNA.
HQIllkirch-Graffenstaden, FR

Latest Updates

Employees (est.) (Jul 2021)101(+4%)

Polyplus-transfection Office Locations

Polyplus-transfection has offices in Illkirch-Graffenstaden and New York
Illkirch-Graffenstaden, FR (HQ)
Bioparc 3, 850 boulevard Sébastien Brant
New York, NY, US
1251 6th Ave 3rd fl
Show all (2)

Polyplus-transfection Financials and Metrics

Summary Metrics

Founding Date


Polyplus-transfection total Funding

$3.2 m

Polyplus-transfection latest funding size

$3.23 m

Time since last funding

11 years ago

Polyplus-transfection investors

Polyplus-transfection's latest funding round in January 2011 was reported to be $3.2 m. In total, Polyplus-transfection has raised $3.2 m
Show all financial metrics

Polyplus-transfection Online and Social Media Presence

Embed Graph

Polyplus-transfection Blogs

Reduce manufacturing costs of AAV-based therapy with FectoVIR®-AAV transfection reagent

This case study theoretically compares 3 processes in 500 L bioreactors with FectoVIR®-AAV, PEIpro® and another commercially available PEI transfection reagent to achieve the same viral titer yield: 8,8×1018 VG needed to produce 1000 doses of Zologensma®.  This table shows a synthesis of the product…

Polyplus invests in Shanghai commercial offices to expand localized cell and gene therapy sector supply

Strasbourg, France, July 28, 2021 – Polyplus-transfection® SA, a leading provider of research through commercial grade upstream process solutions for advanced biologic and cell and gene therapy production, today announces it is investing in new commercial offices to increase the footprint and servic…

Lentiviral transfection for advancing cell-based gene therapy

Lentiviral vectors for gene therapy The use of lentiviruses as vectors for the delivery of genetic cargo has been well established across many disciplines, from cancer to cariology. Their efficiency has made them valuable tools not only for in vitro gene expression assays and cell functionality test…

Bioprocessing Summit US 2021

Talk  Optimizing transfection process in suspension cells to reduce dramatically the cost of goods of AAV gene therapy. AAV-based gene therapy products have demonstrated promising results in clinical trials, but their manufacturing costs are so high that these treatments may not be affordable for mo…

Suspension-based production of lentiviral vectors for CAR T cell therapies

Authors: Diana Riethmüller, Dr Alengo Nyamay’antu, Dr Franziska Bollmann. 10.18609/cgti.2021.099 Citation: Cell & Gene Therapy Insights 2021; 7(6), 689–700 Cell and gene-based therapies present a new treatment paradigm that have the potential to address clinical needs that are unmet by current …

FEBS Congress

Talk: Efficient DNA transfection solutions for Life Science research and Recombinant Protein expression Presented by Maria Nicla LOVIGLIO , Scientific Support Specialist at Polyplus-transfection® Wednesday July 7th , from 1:00 pm-1:20 pm CEST.   Our solutions for both protein and virus production Fe…
Show more

Polyplus-transfection Frequently Asked Questions

  • When was Polyplus-transfection founded?

    Polyplus-transfection was founded in 2002.

  • How many employees does Polyplus-transfection have?

    Polyplus-transfection has 101 employees.

  • Who are Polyplus-transfection competitors?

    Competitors of Polyplus-transfection include Applied Biological Materials, Applied Molecular Transport and Braeburn Pharmaceuticals.

  • Where is Polyplus-transfection headquarters?

    Polyplus-transfection headquarters is located at Bioparc 3, 850 boulevard Sébastien Brant, Illkirch-Graffenstaden.

  • Where are Polyplus-transfection offices?

    Polyplus-transfection has offices in Illkirch-Graffenstaden and New York.

  • How many offices does Polyplus-transfection have?

    Polyplus-transfection has 2 offices.